Lidocaine 40 MG/ML / menthol 10 MG/ML Topical Solution — RxCUI 252967
RxNorm drug concept · Semantic clinical drug
RxCUI 252967
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
11 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI252967
Official nameLidocaine 40 MG/ML / menthol 10 MG/ML Topical Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslidocaine 4 % / menthol 1 % Topical Solution
FDA products mapped2
Package NDCs mapped11
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Lidocaine Transdermal Patch: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It relieves nerve pain from post-herpetic neuralgia, the lingering pain that can follow shingles. It is used in adults. It numbs the pain signals in the skin under the patch.
- Usually up to 12 hours in a 24-hour period, then 12 hours off. Put it on intact skin over the most painful spot. Do not use more patches than prescribed.
- No. Heat can increase how much lidocaine gets absorbed. With Ztlido, you can apply a patch after brief heat, but never put a heating pad or electric blanket directly on it.
- For Ztlido, light exercise and short water exposure, like a 10-minute shower, are okay. Gently pat it dry rather than rubbing. If the edges lift, press them down.
🕸️ Concept Web — How Lidocaine 40 MG/ML / menthol 10 MG/ML Topical So... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Lidocaine 40 MG/ML / menthol 10 MG/ML Topical Solution
RxCUI 252967 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Lidocaine
6387IN -
Menthol
6750IN -
Lidocaine / menthol
1008818MIN
-
Lidocaine
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Lidocaine / menthol Topical Solution
375139SCDF -
Lidocaine / menthol Topical Product
1164045SCDG -
Topical Solution
316986DF -
Topical Product
1151122DFG
-
Lidocaine / menthol Topical Solution
-
Clinical & branded drugs 2
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Lidocaine 40 MG/ML
330627SCDC -
Menthol 10 MG/ML
340163SCDC
-
Lidocaine 40 MG/ML
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Lidocaine 40 MG/ML
SCDC · 330627 -
Menthol 10 MG/ML
SCDC · 340163 -
Lidocaine / menthol Topical Solution
SCDF · 375139 -
Lidocaine / menthol Topical Product
SCDG · 1164045
📦 FDA Products & Package NDCs
2 products · 11 package NDCs
11 package NDCs map to RxCUI 252967 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 71323-0202-00 | 100 mL in 1 BOTTLE, PLASTIC (71323-202-00) | PICKLEBALM LIDOCAINE WITH MENTHOL ARNICA CUCUMBER SEED ROLL ON | Compass Health Brands Corp. | 2025-06-01 |
| 84165-0017-01 | 1 BOTTLE in 1 BOX (84165-017-01) / 73 mL in 1 BOTTLE | FOOT PAIN RELIEF ROLL-ON | Guangzhou Zhupuyou E-commerce Co., Ltd | 2025-11-19 |
| 84165-0017-02 | 2 BOTTLE in 1 BOX (84165-017-02) / 73 mL in 1 BOTTLE | FOOT PAIN RELIEF ROLL-ON | Guangzhou Zhupuyou E-commerce Co., Ltd | 2025-11-19 |
| 84165-0017-03 | 3 BOTTLE in 1 BOX (84165-017-03) / 73 mL in 1 BOTTLE | FOOT PAIN RELIEF ROLL-ON | Guangzhou Zhupuyou E-commerce Co., Ltd | 2025-11-19 |
| 84165-0017-04 | 4 BOTTLE in 1 BOX (84165-017-04) / 73 mL in 1 BOTTLE | FOOT PAIN RELIEF ROLL-ON | Guangzhou Zhupuyou E-commerce Co., Ltd | 2025-11-19 |
| 84165-0017-05 | 5 BOTTLE in 1 BOX (84165-017-05) / 73 mL in 1 BOTTLE | FOOT PAIN RELIEF ROLL-ON | Guangzhou Zhupuyou E-commerce Co., Ltd | 2025-11-19 |
| 84165-0017-06 | 6 BOTTLE in 1 BOX (84165-017-06) / 73 mL in 1 BOTTLE | FOOT PAIN RELIEF ROLL-ON | Guangzhou Zhupuyou E-commerce Co., Ltd | 2025-11-19 |
| 84165-0017-07 | 7 BOTTLE in 1 BOX (84165-017-07) / 73 mL in 1 BOTTLE | FOOT PAIN RELIEF ROLL-ON | Guangzhou Zhupuyou E-commerce Co., Ltd | 2025-11-19 |
| 84165-0017-08 | 8 BOTTLE in 1 BOX (84165-017-08) / 73 mL in 1 BOTTLE | FOOT PAIN RELIEF ROLL-ON | Guangzhou Zhupuyou E-commerce Co., Ltd | 2025-11-19 |
| 84165-0017-09 | 9 BOTTLE in 1 BOX (84165-017-09) / 73 mL in 1 BOTTLE | FOOT PAIN RELIEF ROLL-ON | Guangzhou Zhupuyou E-commerce Co., Ltd | 2025-11-19 |
| 84165-0017-10 | 10 BOTTLE in 1 BOX (84165-017-10) / 73 mL in 1 BOTTLE | FOOT PAIN RELIEF ROLL-ON | Guangzhou Zhupuyou E-commerce Co., Ltd | 2025-11-19 |
Observed labelers:
Guangzhou Zhupuyou E-commerce Co., Ltd (10) ·
Compass Health Brands Corp. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.